Please select the option that best describes you:

Would you treat extranodal extension WITHIN a matted nodal mass differently than at the surface in the postoperative setting for H&N cancer?  

In the case of a nodal mass of several nodes matted together due to ENE but without apparent ENE at the surface, does your management change?

Is ENE considered a high risk feature because of its potential to have microscopic spread, or does the mere presence of ENE denote aggressive biology and warrant more intense treatment?



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more